Deserpidine / methyclothiazide Pregnancy and Breastfeeding Warnings
Brand names: Enduronyl, Enduronyl Forte
Deserpidine / methyclothiazide Pregnancy Warnings
Deserpidine-methyclothiazide has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted. There are no controlled data in human pregnancy. Deserpidine-methyclothiazide should only be given during pregnancy when need has been clearly established.
Deserpidine / methyclothiazide Breastfeeding Warnings
Deserpidine and methyclothiazide are excreted into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2001) "Product Information. Enduronyl (deserpidine-methyclothiazide)." Abbott Pharmaceutical
References for breastfeeding information
- (2001) "Product Information. Enduronyl (deserpidine-methyclothiazide)." Abbott Pharmaceutical
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.